Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model

Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association

Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149

Cardiac excitation–contraction coupling

Bers, D., & Despa, S. (2002) · Nature · doi:10.1038/415198a · Cited by 4,927

The epidemiology of heart failure: The Framingham Study

Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,246

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients

Flather, M. D., Yusuf, S., Køber, L., Pfeffer, M. A., Hall, A. S., Murray, G. D., Torp-Pedersen, C. T., Ball, S. G., Pogue, J. M., Moyé, L. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02212-1 · Cited by 1,585

Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.

Gwathmey, J. K., Copelas, L., MacKinnon, R., Schöen, F. J., Feldman, M. D., Grossman, W., & Morgan, J. P. (1987) · Circulation Research · doi:10.1161/01.res.61.1.70 · Cited by 924

Energy metabolism in heart failure

Ventura‐Clapier, R., Garnier, A., & Veksler, V. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055095 · Cited by 514

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human

Haghighi, K., Kolokathis, F., Pater, L., Lynch, R. A., Asahi, M., Gramolini, A. O., Fan, G.-C., Tsiapras, D., Hahn, H. S., Adamopoulos, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17892 · Cited by 478

Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction

Greenberg, B., Quiñones, M. A., Koilpillai, C. J., Limacher, M. C., Shindler, D. M., Benedict, C. R., & Shelton, B. J. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473

Systolic Heart Failure

McMurray, J. J. V. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp0909392 · Cited by 464

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

Müller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A., & Trepel, M. (2003) · Nature Biotechnology · doi:10.1038/nbt856 · Cited by 411

Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome

Kranias, E. G., & Hajjar, R. J. (2012) · Circulation Research · doi:10.1161/circresaha.111.259754 · Cited by 533

Small and large animal models in cardiac contraction research: advantages and disadvantages

Milani-Nejad, N., & Janssen, P. M. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.007 · Cited by 484

The AAV Vector Toolkit: Poised at the Clinical Crossroads

Asokan, A., Schaffer, D. V., & Samulski, R. J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.287 · Cited by 480

Viral Vectors for Gene Therapy: Translational and Clinical Outlook

Kotterman, M. A., Chalberg, T. W., & Schaffer, D. V. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104938 · Cited by 424

S100 Proteins As an Important Regulator of Macrophage Inflammation

Xia, C. Q., Braunstein, Z., Toomey, A. C., Zhong, J., & Rao, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01908 · Cited by 432

Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality

Hudry, E., & Vandenberghe, L. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.017 · Cited by 384

Mechanisms of Altered Ca 2+ Handling in Heart Failure

Luo, M., & Anderson, M. E. (2013) · Circulation Research · doi:10.1161/circresaha.113.301651 · Cited by 392

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview

Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Cells · doi:10.3390/cells12050785 · Cited by 339

MicroRNA Therapeutics: the Next Magic Bullet?

Simonson, B., & Das, S. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150324123208 · Cited by 266

Reverse remodeling in heart failure—mechanisms and therapeutic opportunities

Koitabashi, N., & Kass, D. A. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.172 · Cited by 241

Heart failure with reduced ejection fraction

Bloom, M. W., Greenberg, B., Jaarsma, T., Januzzi, J. L., Lam, C. S. P., Maggioni, A. P., Trochu, J., & Butler, J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.58 · Cited by 239

Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy

Moretti, A., Fonteyne, L. M., Giesert, F., Hoppmann, P., Meier, A. B., Bozoglu, T. M., Baehr, A., Schneider, C. M., Sinnecker, D., Klett, K., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0738-2 · Cited by 241

Injectable and conductive cardiac patches repair infarcted myocardium in rats and minipigs

Wang, L., Liu, Y., Ye, G., He, Y., Li, B., Guan, Y., Gong, B., Mequanint, K., Xing, M. M. Q., & Qiu, X. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00796-9 · Cited by 207

Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy

Kho, C., Lee, A., & Hajjar, R. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.145 · Cited by 177

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Mearini, G., Stimpel, D., Geertz, B., Weinberger, F., Krämer, E., Schlossarek, S., Mourot-Filiatre, J., Stoehr, A., Dutsch, A., Wijnker, P. J. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6515 · Cited by 172

Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation

Rincón, M. Y., VandenDriessche, T., & Chuah, M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv205 · Cited by 174

Cardiovascular Gene Therapy: Past, Present, and Future

Ylä‐Herttuala, S., & Baker, A. H. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.027 · Cited by 166

AAV6. ARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model

Raake, P. W. J., Schlegel, P., Ksienzyk, J., Reinkober, J., Barthelmes, J., Schinkel, S., Pleger, S. T., Mier, W., Haberkorn, U., Koch, W. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr447 · Cited by 164

Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts

Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., Patterson, N. L., & McMullen, J. R. (2017) · Physiological Reviews · doi:10.1152/physrev.00043.2016 · Cited by 172

Gene therapy for the treatment of heart failure: promise postponed

Hulot, J.-S., Ishikawa, K., & Hajjar, R. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw019 · Cited by 150

Gene Therapy for the Heart Lessons Learned and Future Perspectives

Cannata, A. N., Ali, H., Sinagra, G., & Giacca, M. (2020) · Circulation Research · doi:10.1161/circresaha.120.315855 · Cited by 156

Gene Therapy for Heart Failure

Tilemann, L. M., Ishikawa, K., Weber, T., & Hajjar, R. J. (2012) · Circulation Research · doi:10.1161/circresaha.111.252981 · Cited by 142

Adeno-Associated Virus Vectors as Therapeutic and Investigational Tools in the Cardiovascular System

Zacchigna, S., Zentilin, L., & Giacca, M. (2014) · Circulation Research · doi:10.1161/circresaha.114.302331 · Cited by 144

Targets for therapy in sarcomeric cardiomyopathies

Tardiff, J. C., Carrier, L., Bers, D. M., Poggesi, C., Ferrantini, C., Coppini, R., Maier, L. S., Ashrafian, H., Huke, S., & van der Velden, J. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv023 · Cited by 137

Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction Through Cytokinesis of Adult Cardiomyocytes

Shapiro, S., Ranjan, A. K., Kawase, Y., Cheng, R. K.-H., Kara, R. J., Bhattacharya, R., Guzmán, G., Sanz, J., Garcia, M. J., & Chaudhry, H. W. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007668 · Cited by 130

lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth

Li, H., Trager, L. E., Liu, X., Hastings, M. H., Xiao, C., Guerra, J. R. B., To, S., Li, G., Yeri, A., Rodosthenous, R. S., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056850 · Cited by 116

Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy

Cannavò, A., Liccardo, D., & Koch, W. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00264 · Cited by 115

Cardiac contractility modulation therapy in advanced systolic heart failure

Lyon, A. R., Samara, M. A., & Feldman, D. S. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.114 · Cited by 94

Extracellular Vesicle–Encapsulated Adeno-Associated Viruses for Therapeutic Gene Delivery to the Heart

Li, X., Salvia, S. L., Liang, Y., Adamiak, M., Kohlbrenner, E., Jeong, D., Chepurko, E., Ceholski, D. K., López-Gordo, E., Yoon, S., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.063759 · Cited by 92

Heme Oxygenase-1 Gene Therapy Provides Cardioprotection Via Control of Post-Ischemic Inflammation

Hinkel, R., Lange, P., Petersen, B., Gottlieb, E., Ng, J. K. M., Finger, S., Horstkotte, J., Lee, S.-M., Thormann, M., Knorr, M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.064 · Cited by 86

S100A1 Genetically Targeted Therapy Reverses Dysfunction of Human Failing Cardiomyocytes

Brinks, H., Rohde, D., Völkers, M., Qiu, G., Pleger, S. T., Herzog, N., Rabinowitz, J., Ruhparwar, A., Silvestry, S., Lerchenmüller, C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.054 · Cited by 75

Cardiac gene therapy with adeno-associated virus-based vectors

Chamberlain, K., Riyad, J. M., & Weber, T. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000386 · Cited by 75

Conceptual and technical aspects of transfection and gene delivery

Kaestner, L., Scholz, A., & Lipp, P. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.01.018 · Cited by 73

Targeting Cardiac Hypertrophy

Bisping, E. H., Wakula, P., Poteser, M., & Heinzel, F. R. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000126 · Cited by 73

Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges

Kwekkeboom, R. F. J., Lei, Z., Doevendans, P. A., Musters, R. J. P., & Sluijter, J. P. G. (2014) · Clinical Science · doi:10.1042/cs20140005 · Cited by 73

Preclinical models of myocardial infarction: from mechanism to translation

Martin, T. P., MacDonald, E. A., Elbassioni, A. A. M., O'Toole, D., Zaeri, A. A. I., Nicklin, S. A., Gray, G. A., & Loughrey, C. M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15595 · Cited by 71

Large Animal Models of Heart Failure

Silva, K. A. S., & Emter, C. A. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.04.011 · Cited by 73

Gene therapy strategies in the treatment of hypertrophic cardiomyopathy

Prondzynski, M., Mearini, G., & Carrier, L. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2173-5 · Cited by 68

Heart Failure Gene Therapy

Pleger, S. T., Brinks, H., Ritterhoff, J., Raake, P. W. J., Koch, W. J., Katus, H. A., & Most, P. (2013) · Circulation Research · doi:10.1161/circresaha.113.300269 · Cited by 65

AAV-mediated gene therapy: Advancing cardiovascular disease treatment

Zhang, H., Qi, Z., Huang, B., Wang, Y., & Wang, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.952755 · Cited by 73

Current Landscape of Heart Failure Gene Therapy

Kieserman, J. M., Myers, V. D., Dubey, P. K., Cheung, J. Y., & Feldman, A. M. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012239 · Cited by 64

Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy

Schmid, E., Neef, S., Berlin, C., Tomasovic, A., Kahlert, K., Nordbeck, P., Deiss, K., Denzinger, S., Herrmann, S., Wettwer, E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3972 · Cited by 63

Genetically Encoded Ca 2+ Indicators in Cardiac Myocytes

Kaestner, L., Scholz, A., Tian, X. Y., Ruppenthal, S., Tabellion, W., Wiesen, K., Katus, H. A., Müller, O. J., Kotlikoff, M. I., & Lipp, P. (2014) · Circulation Research · doi:10.1161/circresaha.114.303475 · Cited by 63

Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer

Fang, H., Lai, N. C., Gao, M. H., Miyanohara, A., Roth, D. M., Tang, T., & Hammond, H. K. (2012) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.105 · Cited by 58

Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects

Tomasovic, A., Brand, T., Schanbacher, C., Kramer, S., Hümmert, M. W., Godoy, P., Schmidt‐Heck, W., Nordbeck, P., Ludwig, J., Homann, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15505-4 · Cited by 61

Gene therapy for ischaemic heart disease and heart failure

Korpela, H., Järveläinen, N., Siimes, S., Lampela, J., Airaksinen, J., Valli, K., Turunen, M., Pajula, J., Nurro, J., & Ylä‐Herttuala, S. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13308 · Cited by 59

The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases

Sattar, Z., Lora, A., Jundi, B., Railwah, C., & Geraghty, P. M. (2021) · Pulmonary Medicine · doi:10.1155/2021/5488591 · Cited by 58

Cardiovascular gene therapy for myocardial infarction

Scimia, M. C., Gumpert, A. M., & Koch, W. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.866085 · Cited by 56

Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9

Dashkoff, J., Lerner, P., Truong, N., Klickstein, J. A., Fan, Z., Mu, D., Maguire, C. A., Hyman, B. T., & Hudry, E. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.81 · Cited by 57

Characterizing preclinical models of ischemic heart failure: differences between LAD and LCx infarctions

Ishikawa, K., Agüero, J., Tilemann, L. M., Ladage, D., Hammoudi, N., Kawase, Y., Santos‐Gallego, C. G., Fish, K. M., Levine, R. A., & Hajjar, R. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00797.2013 · Cited by 55

Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump

Kho, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1185261 · Cited by 52

The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy

Sanganalmath, S. K., Dubey, S., Veeranki, S., Narisetty, K. K., & Krishnamurthy, P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01755-1 · Cited by 55

Large Animal Models for Left Ventricular Assist Device Research and Development

Monreal, G., Sherwood, L. C., Sobieski, M., Giridharan, G., Slaughter, M., & Koenig, S. (2014) · ASAIO journal (1992) · doi:10.1097/mat.0000000000000005 · Cited by 42

Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy

Samuel, T., Rosenberry, R., Lee, S., & Pan, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041086 · Cited by 50

Targeting S100A1 in heart failure

Ritterhoff, J., & Most, P. (2012) · Gene Therapy · doi:10.1038/gt.2012.8 · Cited by 50

Adeno-associated virus-mediated gene therapy in cardiovascular disease

Hammoudi, N., Ishikawa, K., & Hajjar, R. J. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000159 · Cited by 49

Gene delivery technologies for cardiac applications

Katz, M. G., Fargnoli, A. S., Pritchette, L. A., & Bridges, C. R. (2012) · Gene Therapy · doi:10.1038/gt.2012.11 · Cited by 49

Calcium mishandling in diastolic dysfunction: Mechanisms and potential therapies

Asp, M. L., Martindale, J. J., Heinis, F. I., Wang, W., & Metzger, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.09.007 · Cited by 49

Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction

Pinilla-Vera, M., Hahn, V. S., & Kass, D. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313682 · Cited by 52

Molecular targets in heart failure gene therapy: current controversies and translational perspectives

Kairouz, V., Lipskaia, L., Hajjar, R. J., & Chemaly, E. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06520.x · Cited by 48

Human Cardiomyocyte Calcium Handling and Transverse Tubules in Mid-Stage of Post-Myocardial-Infarction Heart Failure

Høydal, M. A., Kirkeby‐Garstad, I., Karevold, A., Wiseth, R., Haaverstad, R., Wahba, A., Stølen, T., Contu, R., Condorelli, G., Ellingsen, Ø., et al. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12271 · Cited by 46

Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure

Bass-Stringer, S., Bernardo, B. C., May, C. N., Thomas, C. J., Weeks, K. L., & McMullen, J. R. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.03.005 · Cited by 46

MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction

Behrens‐Gawlik, V., Mearini, G., Gedicke, C., Richard, P., & Carrier, L. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1409-7 · Cited by 47

Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7

Katoh, M., Nomura, S., Yamada, S., Ito, M., Hayashi, H., Katagiri, M., Heryed, T., Fujiwara, T., Takeda, N., Nishida, M., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.064719 · Cited by 45

Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias

Njegić, A., Wilson, C., & Cartwright, E. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01068 · Cited by 45

Ribonucleotide Reductase-Mediated Increase in dATP Improves Cardiac Performance Via Myosin Activation in a Large Animal Model of Heart Failure

Kadota, S., Carey, J. A., Reinecke, H., Leggett, J. H., Teichman, S. L., Laflamme, M. A., Murry, C. E., Regnier, M., & Mahairas, G. G. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.270 · Cited by 43

S100A1: a Major Player in Cardiovascular Performance

Duarte-Costa, S., Castro‐Ferreira, R., Neves, J. S., & Leite-Moreira, A. F. (2014) · Physiological Research · doi:10.33549/physiolres.932712 · Cited by 42

REEP5 depletion causes sarco-endoplasmic reticulum vacuolization and cardiac functional defects

Lee, S.-H., Hadipour-Lakmehsari, S., Murthy, H. R., Gibb, N., Miyake, T., Teng, A. C. T., Cosme, J., Yu, J. C., Moon, M., Lim, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14143-9 · Cited by 42

Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model

Weber, C., Neacsu, I., Krautz, B., Schlegel, P., Sauer, S. W., Raake, P. W. J., Ritterhoff, J., Jungmann, A., Remppis, A. B., Stangassinger, M., et al. (2013) · Gene Therapy · doi:10.1038/gt.2013.63 · Cited by 41

Mechanisms of Myocardial Reverse Remodelling and Its Clinical Significance: A Scientific Statement of the ESC Working Group on Myocardial Function

Falcão‐Pires, I., Ferreira, A. F., Trindade, F., Bertrand, L., Ciccarelli, M., Visco, V., Dawson, D. K., Hamdani, N., Laake, L. W. V., Lezoualc’h, F., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3264 · Cited by 47

Chronic heart failure: Ca 2+ , catabolism, and catastrophic cell death

Cho, G. W., Altamirano, F. J., & Hill, J. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.011 · Cited by 40

Contemporary Animal Models For Human Gene Therapy Applications

Gopinath, C., Nathar, T. J., Ghosh, A., Hickstein, D. D., & Nelson, E. J. R. (2015) · Current Gene Therapy · doi:10.2174/1566523215666150929110424 · Cited by 44

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment

Cheng, Z., Fang, T., Huang, J., Guo, Y., Alam, M., & Qian, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.722340 · Cited by 40

Endothelial Retargeting of AAV9 In Vivo

Bozoglu, T. M., Lee, S.-M., Ziegler, T., Jurisch, V., Maas, S. L., Baehr, A., Hinkel, R., Hoenig, A., Hariharan, A., Kim, C. I., et al. (2022) · Advanced Science · doi:10.1002/advs.202103867 · Cited by 39

Use of Adeno-Associated Virus Vector for Cardiac Gene Delivery in Large-Animal Surgical Models of Heart Failure

Katz, M. G., Fargnoli, A. S., Weber, T., Hajjar, R. J., & Bridges, C. R. (2017) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2017.070 · Cited by 38

The Future of Heart Transplantation

KOBASHIGAWA, J. A. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04223.x · Cited by 39

An Emerging Adeno-Associated Viral Vector Pipeline for Cardiac Gene Therapy

Asokan, A., & Samulski, R. J. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.2515 · Cited by 38

Gene Therapy for Heart Failure: New Perspectives

Gabisonia, K., & Recchia, F. A. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0410-z · Cited by 36

Introducing Genes to the Heart: All About Delivery

Hajjar, R. J., & Ishikawa, K. (2017) · Circulation Research · doi:10.1161/circresaha.116.310039 · Cited by 36

Progress in the treatment of diabetic cardiomyopathy, a systematic review

Shou, Y., Li, X. M., Fang, Q., Xie, A., Zhang, Y., Fu, X., Wang, M., Gong, W., Zhang, X., & Yang, D. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1177 · Cited by 36

S100 proteins in cardiovascular diseases

Zhou, Y., Zha, Y., Yang, Y., Ma, T., Li, H., & Liang, J. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00662-1 · Cited by 35

Application of Mutated miR-206 Target Sites Enables Skeletal Muscle-specific Silencing of Transgene Expression of Cardiotropic AAV9 Vectors

Geisler, A., Schön, C., Größl, T., Pinkert, S., Stein, E. A., Kurreck, J., Vetter, R., & Fechner, H. (2013) · Molecular Therapy · doi:10.1038/mt.2012.276 · Cited by 36

Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review

Imbalzano, E., Mandraffino, G., Casciaro, M., Quartuccio, S., Saitta, A., & Gangemi, S. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9529-8 · Cited by 35

Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling

Jean‐Charles, P., Yu, S. M.-W., Abraham, D., Kommaddi, R. P., Mao, L., Strachan, R. T., Zhang, Z.-S., Bowles, D. E., Brian, L., Stiber, J. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95998 · Cited by 35

Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1

Yamaguchi, N., Chakraborty, A., Huang, T.-Q., Xu, L., Gomez, A. C., Pasek, D. A., & Meissner, G. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00144.2013 · Cited by 34

S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor·Calmodulin Complex

Rebbeck, R. T., Nitu, F. R., Rohde, D., Most, P., Bers, D. M., Thomas, D. D., & Cornea, R. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713107 · Cited by 34

Chronic isoprenaline/phenylephrine vs. exclusive isoprenaline stimulation in mice: critical contribution of alpha1-adrenoceptors to early cardiac stress responses

Dewenter, M., Pan, J., Knödler, L., Tzschöckel, N., Henrich, J., Cordero, J., Dobreva, G. D., Lutz, S., Backs, J., Wieland, T., et al. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00920-z · Cited by 33

Role of S100A1 in hypoxia-induced inflammatory response in cardiomyocytes via TLR4/ROS/NF-κB pathway

Yu, J., Lu, Y., Li, Y., Xiao, L., Xing, Y., Li, Y., & Wu, L. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12415 · Cited by 32

Guidelines for Translational Research in Heart Failure

Lara‐Pezzi, E., Menasché, P., Trouvin, J., Badimón, L., Ioannidis, J. P. A., Wu, J. C., Hill, J. A., Koch, W. J., Felice, A. F. D., Waele, P. D., et al. (2015) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-015-9606-8 · Cited by 34

Cardiac gene therapy in large animals: bridge from bench to bedside

Ishikawa, K., Tilemann, L. M., Ladage, D., Agüero, J., Leonardson, L., Fish, K. M., & Kawase, Y. (2012) · Gene Therapy · doi:10.1038/gt.2012.3 · Cited by 31

Enhancing the Utility of Adeno-Associated Virus Gene Transfer through Inducible Tissue-Specific Expression

Chen, S., Johnston, J., Sandhu, A., Bish, L. T., Hovhannisyan, R. H., Jno-Charles, O. C., Sweeney, H. L., & Wilson, J. M. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.129 · Cited by 31

Deep Characterization of Circular RNAs from Human Cardiovascular Cell Models and Cardiac Tissue

Jakobi, T., Siede, D., Eschenbach, J., Heumüller, A. W., Busch, M., Nietsch, R., Meder, B., Most, P., Dimmeler, S., Backs, J., et al. (2020) · Cells · doi:10.3390/cells9071616 · Cited by 31

Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade

Reinkober, J., Tscheschner, H., Pleger, S. T., Most, P., Katus, H. A., Koch, W. J., & Raake, P. W. J. (2012) · Gene Therapy · doi:10.1038/gt.2012.9 · Cited by 29

Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts

Powers, J. D., Kooiker, K. B., Mason, A. B., Teitgen, A. E., Flint, G. V., Tardiff, J. C., Schwartz, S. D., McCulloch, A. D., Regnier, M., Davis, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142446 · Cited by 27

Raf kinase inhibitor protein: lessons of a better way for β‐adrenergic receptor activation in the heart

Lorenz, K., Rosner, M. R., Brand, T., & Schmitt, J. P. (2017) · The Journal of Physiology · doi:10.1113/jp274064 · Cited by 26

Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors

García‐Olloqui, P., Rodríguez-Madoz, J. R., Scala, M. D., Abizanda, G., Vales, Á., Olagüe, C., Iglesias‐García, O., Larequi, E., Aguado‐Alvaro, L. P., Ruiz‐Villalba, A., et al. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2974 · Cited by 25

Reynoutrin Improves Ischemic Heart Failure in Rats Via Targeting S100A1

Yang, W., Tu, H., Tang, K., Huang, H., Ou, S., & Wu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.703962 · Cited by 25

Knockout of Sorbin And SH3 Domain Containing 2 (Sorbs2) in Cardiomyocytes Leads to Dilated Cardiomyopathy in Mice

McLendon, J. M., Zhang, X., Matasic, D. S., Kumar, M., Koval, O. M., Grumbach, I. M., Sadayappan, S., London, B., & Boudreau, R. L. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025687 · Cited by 25

Pharmacology of heart failure: From basic science to novel therapies

Lother, A., & Hein, L. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.004 · Cited by 24

Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression

Eden, M., Meder, B., Völkers, M., Poomvanicha, M., Domes, K., Branchereau, M., Marck, P., Will, R., Bernt, A., Rangrez, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11317 · Cited by 24

Abstract 2883: Retroinfusion-facilitated Inotropic AAV9-S100A1 Gene Therapy Restores Global Cardiac Function In A Clinically Relevant Pig Heart Failure Model

Pleger, S. T., Shan, C., Kziencek, J., Mueller, O. J., Bekeredjian, R., Remppis, A. B., Koch, W. J., Katus, H. A., & Most, P. (2008) · Circulation · doi:10.1161/circ.118.suppl_18.s_792 · Cited by 7

Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue

Pleger, S. T., Most, P., Boucher, M., Soltys, S., Chuprun, J. K., Pleger, W., Gao, E., Dasgupta, A., Rengo, G., Remppis, A. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.671701 · Cited by 179

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

Most, P., Pleger, S. T., Völkers, M., Heidt, B., Boerries, M., Weichenhan, D., Löffler, E., Janssen, P. M. L., Eckhart, A. D., Martini, J. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21454 · Cited by 213

Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model

Weber, C., Neacsu, I., Krautz, B., Schlegel, P., Sauer, S. W., Raake, P. W. J., Ritterhoff, J., Jungmann, A., Remppis, A. B., Stangassinger, M., et al. (2013) · Gene Therapy · doi:10.1038/gt.2013.63 · Cited by 41

Cardiac-Targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts

Kehr, D., Salatzki, J., Seger, B., Varadi, K., Birkenstock, J., Schlegel, P., Gao, E., Koch, W. J., Riffel, J., André, F., et al. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.012479 · Cited by 5